Crispin J Miller

Targeted genetic dependency screen facilitates identification of actionable mutations in FGFR4, MAP3K9, and PAK5 in lung cancer

Bohdan Waszkowycz, Crispin J. Miller, Yaoyong Li, 2013, Proceedings of the National Academy of Sciences.

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Mahmood Ayub, Dominic G Rothwell, Caroline Dive, 2014, Nature Medicine.

Gastrointestinal differentiation marker Cytokeratin 20 is regulated by homeobox gene CDX1

Ying Liu, Crispin J. Miller, David Bicknell, 2009, Proceedings of the National Academy of Sciences.

Using large-scale genomics data to identify driver mutations in lung cancer: methods and challenges.

Crispin J. Miller, Christopher Wirth, J. Brognard, 2015, Pharmacogenomics.

An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data

Crispin J. Miller, Tim Yates, M. Okoniewski, 2007, Genome Biology.

Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery.

Crispin J. Miller, Tim Yates, Phil Chapman, 2014, Cancer research.

Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells.

Crispin J. Miller, Andrew Pierce, Claire L. Wilson, 2006, Blood.

Amplification protocols introduce systematic but reproducible errors into gene expression studies.

Crispin J. Miller, Claire L. Wilson, S. Pepper, 2004, BioTechniques.

High correspondence between Affymetrix exon and standard expression arrays.

Crispin J. Miller, M. Okoniewski, S. Pepper, 2007, BioTechniques.